Article Details

Tivozanib Improves Long-Term PFS in Rel/Ref Metastatic Renal Cell Carcinoma

Retrieved on: 2022-11-05 15:22:23

Tags for this article:

Click the tags to see associated articles and topics

Tivozanib Improves Long-Term PFS in Rel/Ref Metastatic Renal Cell Carcinoma. View article details on HISWAI: https://www.cancertherapyadvisor.com/home/news/conference-coverage/ikcs-northamerica-2022/renal-cell-carcinoma-rcc-tivozanib-improves-long-term-survival-pfs/

Excerpt

CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up